Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion description "[The combined therapy of TPL and DDP triggers a synergic apoptosis via inhibiting HSP27 in human gemcitabine-resistant pancreatic carcinoma and has a strong potential to be developed into a new effective regimen for pancreatic cancer treatment.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion evidence source_evidence_literature NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion SIO_000772 22617708 NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion wasDerivedFrom befree-20150227 NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_assertion wasGeneratedBy ECO_0000203 NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.
- befree-20150227 importedOn "2015-02-27" NP812302.RAaaFcEo4VYI5ri5pJcfFYxv3ikncVL9L9UWAhvNFxO4A130_provenance.